For reference, 1 kg equals about 2.2 lb. Dupixent is also used for treating the following in children: EOE in children ages 1 year and older who weigh at least 15 kg (about 30 lb) CRwNP in ...
Sanofi and Regeneron have celebrated a pair of positive clinical trials in inflammatory skin disorders with blockbuster immunology therapy Dupixent that could both lead to new indications for the ...
Sanofi and Regeneron’s immunology juggernaut Dupixent is on the brink of another big new indication after it was recommended by the EMA’s human medicines committee for chronic obstructive ...
Stocks must pass the index committee’s liquidity, size, and profitability screens. The profitability screen requires that the sum of a company’s GAAP earnings over the past four quarters be ...
MoA Aggressive Allocation Fund earns a High Process Pillar rating. The main driver of the rating is its parent firm's excellent long-term risk-adjusted performance, as shown by the firm's average ...
Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...
autoinjector pen severe eosinophilic asthma 12 years and older Dupilumab (Dupixent) Interleukin-4Rα prefilled syringe, autoinjector pen severe eosinophilic asthma 6 years and older Mepolizumab ...
First described nearly 20 years ago, eosinophilic esophagitis (EoE) is an inflammatory disease of the esophagus characterized by eosinophilic infiltration of the esophageal epithelium. Over 50% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results